Skip to content

Effects of different modes of TMS stimulation on sensory function of CPSP and healthy subjects

Effects of different modes of TMS stimulation on sensory function of CPSP and healthy subjects

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055134
Enrollment
Unknown
Registered
2022-01-01
Start date
2022-03-31
Completion date
Unknown
Last updated
2023-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

pcTBS group:pcTBS treatment once a day for 2 weeks
10 Hz r-TMS group:10 Hz repetitive transcranial magnetic stimulation treatment once a day for 2 weeks
sham group:Sham TMS stimulation
Healthy control group:pcTBS treatment once a day for 2 weeks

Sponsors

The First Affiliated Hospital of Fujian University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with first-time, unilateral cerebral hemisphere cerebral infarction confirmed by cranial computed tomography (CT) or magnetic resonance (MRI) examination (The diagnosis conforms to the consensus of ''Key Points for the Diagnosis of Various Major Cerebrovascular Diseases in China 2019'' formulated by the Cerebrovascular Disease Group of the Neurology Branch of the Chinese Medical Association); 2. Aged 20-70 years; no gender limit; 3. The course of the disease is 14 days after the onset; patients with stable disease; 4. Central stroke pain; 5. No cognitive impairment, able to execute simple commands (Minimum Mental State Score MMSE>21); 6. Voluntarily participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Difficulty in communication, with aphasia or severe dysarthria; 2. Moderate to severe spasticity of each affected limb (modified Ashworth score >=2); 3. Severe visual impairment (visual acuity <0.3); 4. Traumatic brain injury or brain tumor; 5. Intracranial metal implants; 6. Serious medical diseases (pacemaker, liver and kidney insufficiency, infectious diseases, etc.); 7. The patient has a history of epilepsy or a family history of epilepsy.

Design outcomes

Primary

MeasureTime frame
Sensory threshold determination;Pain threshold determination;Fugl-Meyer Upper Limb Motor Function Scale;Barthel Index Assessment;Functional near-infrared assessment;

Countries

China

Contacts

Public ContactJia Jie

The First Affiliated Hospital of Fujian University

shannonjj@126.com+86 13611722357

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026